Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2021 Filed Nov 24, 2021 01:25 UTC |
PASQUALONE FRANKSVP, CHIEF BUSINESS OFFICER
|
Tax withholdingOrdinary Shares | 3,779 | $8.36 | $31,592.44 |
DisclosureSEC source: 0001415889-21-005470 · form4-11232021_051132.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, CHIEF BUSINESS OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,783 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| November 19, 2021 Filed Nov 24, 2021 01:22 UTC |
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingOrdinary Shares | 1,350 | $8.36 | $11,286.00 |
DisclosureSEC source: 0001415889-21-005466 · form4-11232021_051122.xml · nonDerivative · entry 1 Hindman Andrew A. · CIK 0001607965 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,258 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. F2 · balance_after: Includes 1228 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2021. Read SEC document |
| November 19, 2021 Filed Nov 24, 2021 01:21 UTC |
SABESAN VIJAYSVP, TECHNICAL OPERATIONS
|
Tax withholdingOrdinary Shares | 5,191 | $8.36 | $43,396.76 |
DisclosureSEC source: 0001415889-21-005464 · form4-11232021_051139.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, TECHNICAL OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,524 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 19:07 UTC |
WORBOYS PHILIP DSVP, Research & Transl Science
|
Tax withholdingOrdinary Shares | 4,307 | $14.05 | $60,513.35 |
DisclosureSEC source: 0001179110-21-008406 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Research & Transl Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,062 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 18:59 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 4,307 | $14.05 | $60,513.35 |
DisclosureSEC source: 0001179110-21-008398 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,732 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 19:03 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 4,307 | $14.05 | $60,513.35 |
DisclosureSEC source: 0001179110-21-008402 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,831 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:05 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 11,404 | $14.05 | $160,226.20 |
DisclosureSEC source: 0001179110-21-008404 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313,414 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:01 UTC |
SABESAN VIJAYSVP, Technical Operations
|
Tax withholdingOrdinary Shares | 5,193 | $14.05 | $72,961.65 |
DisclosureSEC source: 0001179110-21-008400 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,715 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:57 UTC |
PASQUALONE FRANKSVP, Chief Business Officer
|
Tax withholdingOrdinary Shares | 3,779 | $14.05 | $53,094.95 |
DisclosureSEC source: 0001179110-21-008396 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,562 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:55 UTC |
Hindman Andrew A.SVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 17,464 | $14.05 | $245,369.20 |
DisclosureSEC source: 0001179110-21-008394 · edgar.xml · nonDerivative · entry 1 Hindman Andrew A. · CIK 0001607965 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,380 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:52 UTC |
GRAHAM RICHARD ASVP, Development
|
Tax withholdingOrdinary Shares | 6,819 | $14.05 | $95,806.95 |
DisclosureSEC source: 0001179110-21-008392 · edgar.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,205 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:50 UTC |
BRADY ANNPresident, TBIL
|
Tax withholdingOrdinary Shares | 3,169 | $14.05 | $44,524.45 |
DisclosureSEC source: 0001179110-21-008390 · edgar.xml · nonDerivative · entry 1 BRADY ANN · CIK 0001767974 · President, TBIL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,857 F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:20 UTC |
WORBOYS PHILIP DSVP, Research & Transl Science
|
Tax withholdingOrdinary Shares | 4,310 | $17.80 | $76,718.00 |
DisclosureSEC source: 0001179110-21-005854 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Research & Transl Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,369 Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:14 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 4,310 | $17.80 | $76,718.00 |
DisclosureSEC source: 0001179110-21-005846 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,039 Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:18 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 4,310 | $17.80 | $76,718.00 |
DisclosureSEC source: 0001179110-21-005850 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,138 F1 · balance_after: Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:19 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 11,404 | $17.80 | $202,991.20 |
DisclosureSEC source: 0001179110-21-005852 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324,818 F1 · balance_after: Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:16 UTC |
SABESAN VIJAYSVP, Technical Operations
|
Tax withholdingOrdinary Shares | 5,194 | $17.80 | $92,453.20 |
DisclosureSEC source: 0001179110-21-005848 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,908 F1 · balance_after: Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:12 UTC |
PASQUALONE FRANKSVP, Chief Business Officer
|
Tax withholdingOrdinary Shares | 3,779 | $17.80 | $67,266.20 |
DisclosureSEC source: 0001179110-21-005844 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,341 F1 · balance_after: Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:10 UTC |
Hindman Andrew A.SVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 942 | $17.80 | $16,767.60 |
DisclosureSEC source: 0001179110-21-005842 · edgar.xml · nonDerivative · entry 1 Hindman Andrew A. · CIK 0001607965 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,844 F1 · balance_after: Includes 1,082 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:09 UTC |
GRAHAM RICHARD ASVP, Development
|
Tax withholdingOrdinary Shares | 3,410 | $17.80 | $60,698.00 |
DisclosureSEC source: 0001179110-21-005840 · edgar.xml · nonDerivative · entry 1 GRAHAM RICHARD A · CIK 0001820036 · SVP, Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,024 F1 · balance_after: Includes 1,282 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:07 UTC |
BRADY ANNPresident, TBIL
|
Tax withholdingOrdinary Shares | 3,169 | $17.80 | $56,408.20 |
DisclosureSEC source: 0001179110-21-005838 · edgar.xml · nonDerivative · entry 1 BRADY ANN · CIK 0001767974 · President, TBIL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,026 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:12 UTC |
Gunderson Robert V JRDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004698 · edgar.xml · derivative · entry 3 Gunderson Robert V JR · CIK 0001302450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:12 UTC |
Gunderson Robert V JRDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004698 · edgar.xml · nonDerivative · entry 1 Gunderson Robert V JR · CIK 0001302450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,093 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:15 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004706 · edgar.xml · derivative · entry 2 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:15 UTC |
PAKIANATHAN DEEPIKADirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004706 · edgar.xml · nonDerivative · entry 1 PAKIANATHAN DEEPIKA · CIK 0001270734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,895 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 18:14 UTC |
WHITESIDES GEORGE MDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004703 · edgar.xml · derivative · entry 4 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 18:14 UTC |
WHITESIDES GEORGE MDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004703 · edgar.xml · nonDerivative · entry 1 WHITESIDES GEORGE M · CIK 0001233438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,828 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 18:13 UTC |
MALKIEL BURTON GDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004699 · edgar.xml · derivative · entry 3 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 18:13 UTC |
MALKIEL BURTON GDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004699 · edgar.xml · nonDerivative · entry 1 MALKIEL BURTON G · CIK 0001184677 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,605 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:13 UTC |
MITCHELL DEAN JDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004700 · edgar.xml · derivative · entry 2 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:13 UTC |
MITCHELL DEAN JDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004700 · edgar.xml · nonDerivative · entry 1 MITCHELL DEAN J · CIK 0001199297 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,034 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:14 UTC |
YOUNG WILLIAM DDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004705 · edgar.xml · derivative · entry 2 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:14 UTC |
YOUNG WILLIAM DDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004705 · edgar.xml · nonDerivative · entry 1 YOUNG WILLIAM D · CIK 0001217420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,158 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:12 UTC |
BROSHY ERANDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004697 · edgar.xml · derivative · entry 2 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:12 UTC |
BROSHY ERANDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004697 · edgar.xml · nonDerivative · entry 1 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,034 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:13 UTC |
Molineaux SusanDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004701 · edgar.xml · derivative · entry 3 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:13 UTC |
Molineaux SusanDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004701 · edgar.xml · nonDerivative · entry 1 Molineaux Susan · CIK 0001553389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,828 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:14 UTC |
O'Connor DonalDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004702 · edgar.xml · derivative · entry 2 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:14 UTC |
O'Connor DonalDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004702 · edgar.xml · nonDerivative · entry 1 O'Connor Donal · CIK 0001625377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,034 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:11 UTC |
Smaldone Alsup LaurieDirector
|
GrantShare Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $20.35 | $0.00 |
DisclosureSEC source: 0001179110-21-004696 · edgar.xml · derivative · entry 2 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:11 UTC |
Smaldone Alsup LaurieDirector
|
GrantOrdinary Shares | 9,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004696 · edgar.xml · nonDerivative · entry 1 Smaldone Alsup Laurie · CIK 0001589602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,810 Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 19:00 UTC |
WORBOYS PHILIP DSVP, Research & Transl Science
|
SaleOrdinary Shares | 8,829 | $20.00 | $176,580.00 |
DisclosureSEC source: 0001179110-21-003282 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Research & Transl Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,679 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 18:20 UTC |
WORBOYS PHILIP DSVP, Research & Transl Science
|
Tax withholdingOrdinary Shares | 31,887 | $18.79 | $599,156.73 |
DisclosureSEC source: 0001179110-21-002178 · edgar.xml · nonDerivative · entry 1 WORBOYS PHILIP D · CIK 0001668718 · SVP, Research & Transl Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,508 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 18:10 UTC |
PITZER KENNETH RSVP, Prod Strat & Comm Plng
|
Tax withholdingOrdinary Shares | 31,931 | $18.79 | $599,983.49 |
DisclosureSEC source: 0001179110-21-002167 · edgar.xml · nonDerivative · entry 1 PITZER KENNETH R · CIK 0001668775 · SVP, Prod Strat & Comm Plng 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,349 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 18:15 UTC |
Shafer Bradford JEVP, Gen. Counsel, Secretary
|
Tax withholdingOrdinary Shares | 31,869 | $18.79 | $598,818.51 |
DisclosureSEC source: 0001179110-21-002174 · edgar.xml · nonDerivative · entry 1 Shafer Bradford J · CIK 0001302448 · EVP, Gen. Counsel, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,047 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 23:17 UTC |
Winningham Rick EDirector · Chief Executive Officer
|
Tax withholdingOrdinary Shares | 110,348 | $18.79 | $2,073,438.92 |
DisclosureSEC source: 0001179110-21-002176 · edgar.xml · nonDerivative · entry 1 Winningham Rick E · CIK 0001302443 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,334,821 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 23:13 UTC |
SABESAN VIJAYSVP, Technical Operations
|
Tax withholdingOrdinary Shares | 8,343 | $18.79 | $156,764.97 |
DisclosureSEC source: 0001179110-21-002171 · edgar.xml · nonDerivative · entry 1 SABESAN VIJAY · CIK 0001767807 · SVP, Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,701 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 23:09 UTC |
PASQUALONE FRANKSVP, Chief Business Officer
|
Tax withholdingOrdinary Shares | 26,961 | $18.79 | $506,597.19 |
DisclosureSEC source: 0001179110-21-002164 · edgar.xml · nonDerivative · entry 1 PASQUALONE FRANK · CIK 0001597334 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,719 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 23:07 UTC |
Hindman Andrew A.SVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 3,984 | $18.79 | $74,859.36 |
DisclosureSEC source: 0001179110-21-002160 · edgar.xml · nonDerivative · entry 1 Hindman Andrew A. · CIK 0001607965 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,704 Read SEC document |
| February 20, 2021 Filed Feb 23, 2021 23:05 UTC |
HAUMANN BRETT KChief Medical Officer
|
Tax withholdingOrdinary Shares | 35,672 | $18.79 | $670,276.88 |
DisclosureSEC source: 0001179110-21-002157 · edgar.xml · nonDerivative · entry 1 HAUMANN BRETT K · CIK 0001607733 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,499 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.